Per Multiple Sclerosis News Today, "Treatment with Ocrevus (ocrelizumab) has superior or comparable effectiveness and a similar safety profile to other available disease-modifying treatments (DMTs) for treating relapsing multiple sclerosis (MS), according to a new review study."
Ocrevus has superior or comparable effec... - My MSAA Community
Ocrevus has superior or comparable effectiveness and a similar safety profile to other available DMTs for RRMS
Written by
sashaming1
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
I saw this article and since I’m on Ocrevus thought 👍👍👍 but I also read that 3 of the 6 authors worked for Genentech/Roche. So a bit of a conflict of interest 🤷♀️
Not what you're looking for?
You may also like...
Hello I am
Hi my name is Danny and I’ve been married for 30 years to a wonderful supportive wife. I’ve been...
Blood Test for MS Activity Gets FDA Breakthrough Designation
The US Food and Drug Administration (FDA) has granted breakthrough device designation to the...
PPMS...
~No l dont have this, but we never do posts on PPMS. (I have been told🤣)~
~Please Let Me Know...
Transcript: Ask Me Anything with Dr. Annette Okai
Welcome, My MSAA Community, to our Ask Me Anything with Dr. Annette Okai! We are excited to have...